[Clinical and immunological improvement of myasthenia gravis following treatment with denosumab].

Rodriguez-Gomez, D

[Clinical and immunological improvement of myasthenia gravis following treatment with denosumab]. [electronic resource] - Revista de neurologia 01 2017 - 47-48 p. digital

Publication Type: Case Reports; Letter

1576-6578


Adrenal Cortex Hormones--adverse effects
Aged, 80 and over
Autoantibodies--blood
Autoantigens--immunology
Denosumab--therapeutic use
Female
Fractures, Spontaneous--chemically induced
Humans
Myasthenia Gravis--complications
Osteoporosis--chemically induced
Pyridostigmine Bromide--therapeutic use
RANK Ligand--antagonists & inhibitors
Receptors, Cholinergic--immunology
Remission Induction